Morningstar Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-675
Closed -$237K 329
2025
Q4
$237K Sell
675
-10,889
-94% -$3.68M 0.01% 318
2025
Q3
$3.74M Buy
+11,564
New +$3.6M 0.14% 174

Other funds holding ELV

Morningstar Investment Management's ELV Position: Q1 2026 in Review

Morningstar Investment Management sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 675 shares — an estimated $237K sold.

Morningstar Investment Management first reported a position in ELV in Q3 2025 and held it in 2 quarters. The position peaked at $3.74M in Q3 2025. 1,467 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Morningstar Investment Management reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Morningstar Investment Management sold 675 Elevance Health shares in Q1 2026, an estimated $237K.
  • Morningstar Investment Management first reported a position in Elevance Health in Q3 2025 and held it in 2 quarters.
  • Morningstar Investment Management's Elevance Health position peaked at $3.74M in Q3 2025.
  • 1,467 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Morningstar Investment Management's 13F filing for Q1 2026, filed 14 May 2026.